Back to Search
ANURADHA GAJJAR, M.D.
M.D.
Pediatric Nephrology Physician
NPI: 1720370828Individual
Specialties, Licenses & Credentials
Pediatric Nephrology PhysicianPrimary
Pediatrics — Pediatric Nephrology
Code: 2080P0210X
MD210011566(DC)
Research & Publications (20)
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
PMID 18796696·Neuro Oncol·2009
4-observational
New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.
PMID 19212772·Childs Nerv Syst·2009
8-other
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.
PMID 19147777·Clin Cancer Res·2009
3-trial
Abnormal timing of menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study.
PMID 19309737·Cancer·2009
8-other
Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.
PMID 19484793·Cancer·2009
3-trial
Mechanisms of resistance: useful tool to design antibacterial agents for drug - resistant bacteria.
PMID 19200024·Mini Rev Med Chem·2009
6-review
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
PMID 19373855·J Pathol·2009
8-other
Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
PMID 19530235·Pediatr Blood Cancer·2009
5-case
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma.
PMID 19196975·Proc Natl Acad Sci U S A·2009
7-preclinical
Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts.
PMID 18377301·J Neurosurg Pediatr·2008
8-other
The use of bone age for bone mineral density interpretation in a cohort of pediatric brain tumor patients.
PMID 18769909·Pediatr Radiol·2008
8-other
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
PMID 17892918·Int J Radiat Oncol Biol Phys·2008
3-trial
High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisal.
PMID 18306390·Cancer·2008
8-other
High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors.
PMID 18224664·Cancer·2008
8-other
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
PMID 18318429·Cancer·2008
3-trial
Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
PMID 18309946·J Clin Oncol·2008
3-trial
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
PMID 18669462·J Clin Oncol·2008
2-rct
Young age may predict a better outcome for children with diffuse pontine glioma.
PMID 18484645·Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 MICHIGAN AVE NW
WASHINGTON, DC 20010 - Phone
- (202) 476-5058
Quick Facts
- NPI
- 1720370828
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile